- ¡Intentar construir su término de la búsqueda una a la vez, y ser tan específico como usted puede! Buscar el ejemplo del término: “tos crónica”.
- No incorporar los resultados múltiples tales como "anemia, tos crónica, pérdida de peso, vomitando" todos al mismo tiempo.
- Después de seleccionar su término de la búsqueda resulta una lista de diagnosis posibles será generada. Si la lista es demasiado larga, usted podrá enangostarla abajo incorporando términos adicionales.
- No incorporar los valores tales como "ritmo 110 del corazón" o "sodio 125", en lugar uso "taquicardia" o "hyponatremia".
Información de la droga para PIPRACIL (piperacillin for injection) For Intravenous and Intramuscular Use (Wyeth Pharmaceuticals, Inc.): MICROBIOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- How Supplied
Piperacillin is an antibiotic which exerts its bactericidal activity by inhibiting both septum and cell wall synthesis. It is active against a variety of gram-positive and gram-negative aerobic and anaerobic bacteria. Piperacillin has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section.
Aerobic gram-positive microorganismsEnterococci, including Enterococcus faecalisStreptococcus pneumoniaeStreptococcus pyogenes
Aerobic gram-negative microorganismsAcinetobacter speciesEnterobacter speciesEscherichia coliHaemophilus influenzae (non-β-lactamase-producing strains) Klebsiella speciesMorganella morganiiNeisseria gonorrhoeae Proteus mirabilis Proteus vulgarisProvidencia rettgeri Pseudomonas aeruginosa Serratia species
Anaerobic gram-positive microorganismsAnaerobic cocciClostridium species
Anaerobic gram-negative microorganismsBacteroides species, including Bacteroides fragilis
The following in vitro data are available, but their clinical significance is unknown.
At least 90% of the following microorganisms exhibit an in vitro minimum inhibitory concentration (MIC) less than or equal to the susceptible breakpoint for piperacillin. However, the safety and effectiveness of piperacillin in treating clinical infections due to these microorganisms have not been established in adequate and well-controlled clinical trials.
Aerobic gram-positive microorganismsStreptococcus agalactiaeStreptococcus bovis Viridans group streptococci
Aerobic gram-negative microorganismsBurkholderia cepaciaCitrobacter diversusCitrobacter freundiiPseudomonas fluorescensStenotrophomonas maltophiliaYersinia enterocolitica
Anaerobic gram-positive microorganismsActinomyces speciesEubacterium species
Anaerobic gram-negative microorganismsFusobacterium necrophorumFusobacterium nucleatumPorphyromonas asaccharolyticaPrevotella melaninogenicaVeillonella species
Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on a dilution method1,2 (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of piperacillin powder. The MIC values should be interpreted according to the following criteria:
For testingEnterobacteriaceae and Acinetobacter species:
MIC (μg/mL) Interpretation ≤ 16 32-64 ≥ 128 Susceptible (S) Intermediate (I) Resistant (R)
For testing Pseudomonas aeruginosa:
MIC (μg/mL) Interpretation ≤ 64 ≥ 128 Susceptible (S) Resistant (R)
For testing Enterococcus faecalisa:
MIC (μg/mL) Interpretation
a Penicillin susceptibility may be used to predict the susceptibility to piperacillin.1,2
≤ 8 ≥ 16 Susceptible (S) Resistant (R)
Haemophilus species are considered susceptible if the MIC of piperacillin is≤ to 1 μg/mL.*
* Dilution methods such as those described in the International Collaborative Study (Acta Pathol Microbiol Scand [B] 1971; suppl 217) have been used to determine susceptibility of organisms to piperacillin.
Dilution (MICs) susceptibility test methods and interpretative criteria for assessing the susceptibility of Neisseria gonorrhoeae to piperacillin have not been established. However,β‑lactamase testing will detect one form of penicillin resistance in Neisseria gonorrhoeae and is recommended.1,2
Dilution (MICs) susceptibility test methods and interpretative criteria for assessing the susceptibility of Streptococcus pneumoniae and Streptococcus pyogenes to piperacillin have not been established.1,2
A report of“Susceptible” indicates that the pathogen is likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable. A report of “Intermediate” indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of “Resistant” indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.
Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard piperacillin powder should provide the following MIC values:
Microorganism MIC (μg/mL) Enterococcus faecalisEscherichia coliPseudomonas aeruginosa ATCC 29212 ATCC 25922ATCC 27853 1-4 1-4 1-8
Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure2,3 requires the use of standardized inoculum concentrations. This procedure uses paper disks impregnated with 100μg of piperacillin to test the susceptibility of microorganisms to piperacillin.
Reports from the laboratory providing results of the standard single-disk susceptibility test with a 100 μg piperacillin disk should be interpreted according to the following criteria:
For testing Enterobacteriaceae and Acinetobacter species:
Zone Diameter (mm) Interpretation ≥ 21 18-20 ≤ 17 Susceptible (S) Intermediate (I) Resistant (R)
For testing Pseudomonas aeruginosa:
Zone Diameter (mm) Interpretation ≥ 18 ≤ 17 Susceptible (S) Resistant (R)
For testing Enterococcus faecalisb:
Zone Diameter (mm) Interpretation
b Penicillin susceptibility may be used to predict the susceptibility to piperacillin.2,3
≥ 15 ≤ 14 Susceptible (S) Resistant (R)
Haemophilus species which give zones of ≥ 29 mm are susceptible; resistant strains give zones of ≤ 28 mm. The above interpretive criteria are based on the use of the standardized procedure. Antibiotic susceptibility testing requires carefully prescribed procedures. Susceptibility tests are biased to a considerable degree when different methods are used.
NCCLS Approved Standard; M2-A2 (Formerly ASM-2) Performance Standards for Antimicrobic Disk Susceptibility Tests, Second Edition, available from the National Committee of Clinical Laboratory Standards.
Disk diffusion (zone diameters) susceptibility test methods and interpretative criteria for assessing the susceptibility of Neisseria gonorrhoeae to piperacillin have not been established. However, β-lactamase testing to penicillin is recommended. It will detect one form of penicillin resistance, chromosomally mediated resistance, in Neisseria gonorrhoeae. In addition, gonococci with 10-unit penicillin disk zone diameters of ≤ 19 mm are likely to be β-lactamase producing strains (plasmid-mediated penicillin resistance).2,3
Disk diffusion (zone diameters) susceptibility test methods and interpretative criteria for assessing the susceptibility of Streptococcus pneumoniae and Streptococcus pyogenes to piperacillin have not been established.2,3
Interpretation should be as stated above for results using dilution techniques. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for piperacillin.
Quality Control:As with standardized dilution techniques, diffusion methods require the use of laboratory control microorganisms that are used to control the technical aspects of the laboratory procedures. For the diffusion technique, the 100-μg piperacillin disk should provide the following zone diameters in these laboratory test quality control strains:
Microorganism Zone Diameter (mm) Escherichia coliPseudomonas aeruginosa ATCC 25922 ATCC 27853 24-30 25-33
For anaerobic bacteria, the susceptibility to piperacillin as MICs can be determined by standardized test methods.4 The MIC values obtained should be interpreted according to the following criteria:
MIC (μg/mL) Interpretation ≤ 32 64 ≥ 128 Susceptible (S) Intermediate (I) Resistant (R)
Interpretation is identical to that stated above for results using dilution techniques.
As with other susceptibility techniques, the use of laboratory control microorganisms is required to control the technical aspects of the laboratory standardized procedures. Standardized piperacillin powder should provide the following MIC values:
Microorganism MIC (μg/mL)
c This quality control range is applicable only to tests performed using either Brucella blood agar or Wilkins-Chalgren agar with the Reference Agar Dilution Method.4d This quality range is applicable only to tests performed in the broth formulation of Wilkins-Chalgren agar with the Broth microdilution method.4
Bacteroides fragiliscBacteroides thetaiotaomicrond ATCC 25285 ATCC 29741 2-8 8-32
- Drug Information Provided by National Library of Medicine (NLM).